The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage Wolfgang Brück OriginalPaper Pages: v3 - v9
Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis Wolfgang Brück OriginalPaper Pages: v10 - v15
MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system Massimo FilippiMaria Assunta Rocca OriginalPaper Pages: v16 - v24
Changes observed in multiple sclerosis using magnetic resonance imaging reflect a focal pathology distributed along axonal pathways Douglas L. Arnold OriginalPaper Pages: v25 - v29
Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis Hans-Peter HartungBernd C. KieseierBernhard Hemmer OriginalPaper Pages: v30 - v37
Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis Tjalf Ziemssen OriginalPaper Pages: v38 - v45
Multiple sclerosis trial designs for the 21st century: Building on recent lessons Fred Lublin OriginalPaper Pages: v46 - v53